EUROPEAN MEDICINES AGENCY – SCIENCE MEDICINE HEALTH
Report from ‘Human Medicines Division’, April 3, 2020
Summary on compassionate use
Page 36: Clinical efficacy
“There are no clinical efficacy data to support the compassionate use of remdesivir coming from patients with infection for COVID-19. There are currently several ongoing and planned clinical studies with this regard.”
Source document: https://www.ema.europa.eu/en/documents/other/summary-compassionate-use-remdesivir-gilead_en.pdf